Combining an additional anticancer agent bevacizumab with an existing targeted therapy improved treatment outcomes in ...

LigaChem Biosciences said Friday that it will receive a subsequent development milestone payment from Ono Pharmaceutical of ...

Bayer Korea said Friday it has received approval from the Ministry of Food and Drug Safety to extend the administration cycle of Eylea 8mg (aflibercept 8 mg) from a minimum of four weeks to a maximum ...

The following article has been provided by Vetter Pharma International GmbH as part of its public relations activities. Korea Biomedical Review has no affiliation with, and bears no responsibility for ...

Hanmi Pharmaceutical is moving to take full control of Canada-based Aptose Biosciences, pressing ahead with its first direct ...

Yonsei University College of Medicine Professor Lee Ho-kyou has been appointed as an associate editor of Circulation, the ...

“Although the liver is called the silent organ, in the case of rare liver diseases, the voices of patients seem particularly ...

Starting March 1, cancer immunotherapies Imfinzi (durvalumab) and Keytruda (pembrolizumab), along with targeted therapies ...

Lung cancer, long notorious as Korea's most prevalent cancer with poor treatment outcomes, is undergoing significant change.According to National Cancer Registry statistics, the five-year survival rat ...

If Sam Chun Dang Pharm is right, a slice of Europe’s multibillion-dollar semaglutide market could open to a low-cost challenger years before many competitors are able to enter.That is the wager behind ...

Some 47.7 percent of doctors in Korea have experience with medical AI, with 83.3 percent using it for image interpretation.While using medical AI, they expressed the greatest concern about “the risk o ...

Sixteen Korean university hospitals made the world's top 250 hospitals list, confirming their international competitiveness.Korea ranked third behind the United States and Germany in the number of hos ...